Female Fertility Check II

This focused fertility panel is designed for women who want an early, clinically useful view of ovarian reserve and the hormonal signals that shape the menstrual cycle. It combines anti-Müllerian hormone (AMH) with follicle-stimulating hormone (FSH) and oestradiol (E2) measured in the early follicular phase, giving you and your clinician a clearer picture of ovarian reserve and hormone balance at the start of a cycle.

It can be helpful if you are starting to think about conception, have irregular cycles, have a family history of early menopause, or want to understand your fertility potential before treatment or egg freezing. It is not a pregnancy test and does not confirm infertility on its own; results are interpreted alongside your age, cycle history and clinical context.

Ovarian Reserve and Early Follicular Hormones
- Anti-Müllerian hormone (AMH): produced by small follicles in the ovaries and used as an indicator of ovarian reserve.
- Follicle-stimulating hormone (FSH): measured on days 2 to 5 of the cycle to assess early follicular ovarian response.
- Oestradiol (E2): measured alongside FSH in the early follicular phase to support interpretation of ovarian and hormonal activity.

Why it matters

Fertility planning is often about timing and information. AMH, FSH and E2 together help identify whether ovarian reserve appears typical for your age, whether early cycle hormone signalling is balanced, and whether further fertility assessment may be useful. Early clarity can support more informed conversations with your GP or fertility specialist about conception, lifestyle, treatment options or egg freezing.